Provider of cardiovascular disease management services. The company provides cholesterol balance test and Boston Heart Navigator. It also conducts studies for the pharma industry and health care research organizations to support drug and therapy trials.
Company Status (as of 16-Apr-2015)
The company was acquired by Eurofins Scientific (XPAR: EUFI) for $200 million on February 2, 2015.